Edmund Harrigan Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

PHAS Quotes by TradingView

Edmund Harrigan is Director of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 9,750 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 19, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.75K
0% 3M change
0% 12M change
Total Value Held $0

EDMUND HARRIGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2023
BUY
Exercise of conversion of derivative security
-
3,750 Added 27.78%
9,750 Common Stock
Dec 03 2020
BUY
Open market or private purchase
$24,720 $4.12 p/Share
6,000 Added 50.0%
6,000 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
Director
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
EH

Edmund Harrigan

Director
Wilmington, DE

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAS